Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential

Tomohiro Tamura1,2, Tomonaga Ichikawa2, Shingo Nakahata2

  • 1Division of Oral and Maxillofacial Surgery, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Cancer Research
|February 18, 2017
PubMed

Insights

Loss of NDRG2 (N-myc downstream regulated gene 2) promotes oral squamous cell carcinoma (OSCC) invasion and metastasis. Restoring NDRG2 inhibits tumor growth and spread by suppressing key signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Loss of the tumor suppressor NDRG2 is linked to oral squamous cell carcinoma (OSCC) development.
  • NDRG2 influences the PI3K/AKT pathway, affecting PTEN phosphorylation at specific sites (S380/S382/T383).
  • High phosphorylated AKT-S473 and PTEN-STT levels, with low NDRG2, correlate with lymph node metastasis in OSCC.

Purpose of the Study:

  • To investigate the role of NDRG2 in OSCC invasion and metastasis.
  • To elucidate the molecular mechanisms by which NDRG2 loss promotes OSCC progression.
  • To evaluate NDRG2's potential as a therapeutic target in OSCC.

Main Methods:

  • Utilized a 4-nitroquinoline-1-oxide (4-NQO) induced OSCC mouse model in Ndrg2-deficient mice.
  • Analyzed human OSCC cell lines with varying NDRG2 expression levels.
  • Investigated signaling pathways including PI3K/AKT, PTEN, and NF-κB.

Main Results:

  • Ndrg2 deficiency significantly increased OSCC tumor number, size, and lymph node invasion in mice.
  • Low NDRG2 expression in OSCC cells promoted epithelial-mesenchymal transition (EMT) via NF-κB activation.
  • Ectopic NDRG2 expression reversed EMT and inhibited NF-κB signaling by suppressing PTEN-STT and AKT-S473 phosphorylation.

Conclusions:

  • NDRG2 expression is a critical determinant of OSCC invasiveness and metastatic potential.
  • NDRG2 loss promotes OSCC progression through activation of AKT/PTEN and NF-κB signaling pathways.
  • Restoring NDRG2 function may offer a therapeutic strategy to inhibit OSCC metastasis.